# Xanthohumol as an Adjuvant in the Treatment of Septic Shock

> **NCT06225258** · PHASE2 · RECRUITING · sponsor: **Medical University of Lublin** · enrollment: 50 (estimated)

## Conditions studied

- Septic Shock
- Pneumonia
- ARDS

## Interventions

- **DIETARY_SUPPLEMENT:** Xanthohumol

## Key facts

- **NCT ID:** NCT06225258
- **Lead sponsor:** Medical University of Lublin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-09
- **Primary completion:** 2025-10-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06225258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06225258, "Xanthohumol as an Adjuvant in the Treatment of Septic Shock". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06225258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*